With billions of dollars in federal biomedical research support in question, universities should look to build collaborations with industry, which today provides only about 3 to 8 percent of research funding for the 243 universities ranked as the best in the U.S. for translational science by the Cure Innovation Index. A new Cure analysis finds universities engage industry through four distinct pathways: scientific collaboration, industry-sponsored clinical research, small-business partnerships, and entrepreneurial training. On the first two, the expected pattern holds and top-ranked universities lead. On the second two, it reverses and lower-ranked universities outperform the top-ranked.

The historical carbon emissions of major oil, gas, coal, and cement producers will contribute to global warming for many centuries, per simulations under a range of future emissions scenarios.

GBIF marks its 25th anniversary having grown from 21 founding countries to a network spanning 70 participating countries, 42 other associate participants and crossing 3.8 billion biodiversity records. A new overview, published in the Biodiversity Data Journal, traces GBIF's evolution from natural history collections to DNA and survey data, its role underpinning 15,000+ research papers and major policy frameworks, and the persistent challenges, including geographic and taxonomic data gaps, that remain as the organisation looks toward its next 25 years.